David McIntosh: Egypt Leading the Way in Plasma Self-Sufficiency and Rare Disease Care
David McIntosh, Founder and Chair at United Plasma Action, shared Reza Shojaei‘s post on LinkedIn:
“The Egyptian ‘Lighthouse’ for the Low and Middle Income world.
Reza Shojaei’s fascinatig article on the Grifols/Egyptian Government Plasma Initiative is well worth re-reading – repeatedly – until many more countries are achieving similar progress.
Of course, huge obstacles remain to be overcome, both in terms of full medicines availability and the need for more, and more widespread, diagnostic success.
However, two irreversible and enormous encouraging steps have been taken:
- A national commitment has been established to ensure proper diagnosis and treatment for all rare disease sufferers in the nation; and
- Concrete steps have been taken to ensure reliable delivery of adequate volumes of safe local plasma raw material.
If a hundred or so other countries in the World would do the same thing, many millions of lives could be saved and improved – to the benefit of all Humankind.”
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources shared a post on LinkedIn:
“What if your country could stop depending on imported plasma medicines, permanently?
For decades, most nations accepted plasma dependency as inevitable. Today, one country has proven that assumption wrong.
Egypt is now one of only a few countries in the world to achieve full national self-sufficiency in essential plasma-derived medicines, including IVIG, albumin, and hemophilia clotting factors. And it didn’t take 50 years to execute once the strategy was right; it took just five.
This transformation was not accidental. It was built through:
- Presidential-level political commitment
- A first-of-its-kind public–private joint venture
- FDA-aligned regulation
- Compensated, medically monitored donors
- And full vein-to-vial industrial integration
In this edition of Blood and Plasma Pulse, we unpack Egypt’s 50-year journey from early failed fractionation attempts to becoming Africa’s first plasma manufacturing hub, and what policymakers, regulators, and health system leaders around the world can learn from it, right now.
If your country is facing:
- IVIG shortages
- Rising plasma medicine costs
- Import dependency
- Or national biologics insecurity
This is not a story you can afford to ignore.”
Read the full paper here.
Stay updated with Hemostasis Today.
-
May 9, 2026, 05:03Marlene S: New WFH Initiative on Equity in Bleeding Disorder Care
-
May 9, 2026, 04:49Why Early Recognition in Bleeding Disorders Saves Lives – EHC
-
May 8, 2026, 19:37Mostafa Faisal Mohammed Saleh: Exploring the Role of AI and Learning in Monitoring Iron Overload in Beta-Thalassemia
-
May 8, 2026, 19:27Spelile Mutupira: Hemostasis – How the Body Stops Bleeding Naturally
-
May 8, 2026, 19:15Not All TF Activity Assays Measure Tissue Factor – RPTH Journal
-
May 8, 2026, 18:48Carlos Penalillo Pimentel: Detection of Rare Blood Donor Phenotypes During Investigation of Serologic Discrepancies
-
May 8, 2026, 18:23How SCD Affects Daily Life in sub-Saharan Africa? – American Society of Hematology
-
May 8, 2026, 18:03Risk of Thrombosis After Stopping Anticoagulation in APS With aPL Negativization -JTH
-
May 8, 2026, 17:35Gurpreet Kaur Sagoo: A Rare Bone Marrow Failure Syndrome That Challenges Early Diagnosis